Acepodia, Inc.

TWO:6976 Taiwan Biotechnology
Market Cap
$217.84 Million
NT$7.21 Billion TWD
Market Cap Rank
#17189 Global
#701 in Taiwan
Share Price
NT$12.40
Change (1 day)
-2.36%
52-Week Range
NT$12.40 - NT$19.80
All Time High
NT$41.75
Categories
Companies in Taiwan Biotechnology
About

Acepodia, Inc. operates as a clinical stage biotechnology company. The company engages in developing cell therapies with its antibody cell conjugation (ACC) platform technology to address cancer care. It develops AD2C targeting GPC3 for HCC which is in preclinical stage; ACE 1831 targeting CD20 that is in phase 1 clinical trial; ACE 2016 targeting EGFR, which is in Phase 1 clinical trial; ACE183 … Read more

Acepodia, Inc. (6976) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2024: -0.014x

Based on the latest financial reports, Acepodia, Inc. (6976) has a cash flow conversion efficiency ratio of -0.014x as of June 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-89.07 Million) by net assets (NT$6.59 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Acepodia, Inc. - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how Acepodia, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Acepodia, Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Acepodia, Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193
 		N/A
BEXIMCO PHARMA.GDR REGS 1
F:R2WA
 		N/A
VESTUM AB AK
F:W0S
 		N/A
Young Optics Inc
TW:3504
 		0.021x
Diana Shipping Inc.
NYSE:DSX
 		0.030x
Sichuan Langsha Holding Ltd
SHG:600137
 		-0.016x
Caswell Inc
TW:6416
 		-0.038x
SIERRA MADRE GOLD AND SIL
F:409
 		N/A

Annual Cash Flow Conversion Efficiency for Acepodia, Inc. (2020–2023)

The table below shows the annual cash flow conversion efficiency of Acepodia, Inc. from 2020 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 NT$6.43 Billion NT$-282.72 Million -0.044x -135.49%
2022-12-31 NT$-3.01 Billion NT$-372.78 Million 0.124x -49.33%
2021-12-31 NT$-1.46 Billion NT$-357.93 Million 0.244x +67.84%
2020-12-31 NT$-710.23 Million NT$-103.40 Million 0.146x --